Clinical Trial Update: Personalized Therapy in Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for personalized therapy in non-small cell lung cancer has completed. The summary does not include detailed trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Guangzhou Medical University | Conditions: Lung Cancer, Carboplatin Adverse Reaction | Phase 2 | Status: COMPLETED